Chad M VanDenBerg

Summary

Affiliation: Mercer University
Country: USA

Publications

  1. pmc Duloxetine in the treatment of generalized anxiety disorder
    Alan Wright
    Center for Clinical Research, Mercer University, Atlanta, GA, USA
    Int J Gen Med 2:153-62. 2009
  2. pmc Duloxetine in the treatment of chronic pain due to fibromyalgia and diabetic neuropathy
    Alan Wright
    Center for Clinical Research, Mercer University, Atlanta, Georgia, USA
    J Pain Res 4:1-10. 2011
  3. doi request reprint The transdermal delivery system of monoamine oxidase inhibitors
    Chad M VanDenBerg
    Department of Pharmacy Practice and Center for Clinical Research, Mercer University College of Pharmacy and Health Sciences, Atlanta, GA, USA
    J Clin Psychiatry 73:25-30. 2012
  4. doi request reprint MAOIs and transdermal delivery
    Chad M VanDenBerg
    Department of Pharmacy Practice and the Center for Clinical Research, Mercer University College of Pharmacy and Health Sciences, Atlanta, Georgia, USA
    J Clin Psychiatry 73:e28. 2012

Collaborators

  • Alan Wright
  • Kyle E Luedtke

Detail Information

Publications4

  1. pmc Duloxetine in the treatment of generalized anxiety disorder
    Alan Wright
    Center for Clinical Research, Mercer University, Atlanta, GA, USA
    Int J Gen Med 2:153-62. 2009
    ..In conclusion, duloxetine, a selective inhibitor for the serotonin and norepinephrine transporters, is efficacious in the treatment of GAD, and has a predictable tolerability profile, with AEs generally being mild to moderate...
  2. pmc Duloxetine in the treatment of chronic pain due to fibromyalgia and diabetic neuropathy
    Alan Wright
    Center for Clinical Research, Mercer University, Atlanta, Georgia, USA
    J Pain Res 4:1-10. 2011
    ....
  3. doi request reprint The transdermal delivery system of monoamine oxidase inhibitors
    Chad M VanDenBerg
    Department of Pharmacy Practice and Center for Clinical Research, Mercer University College of Pharmacy and Health Sciences, Atlanta, GA, USA
    J Clin Psychiatry 73:25-30. 2012
    ..In this article, the mechanism of action of MAOIs is reviewed, along with that of a newer MAOI formulation that lessens the need for dietary restrictions and has a greater safety and tolerability profile than the older oral formulations...
  4. doi request reprint MAOIs and transdermal delivery
    Chad M VanDenBerg
    Department of Pharmacy Practice and the Center for Clinical Research, Mercer University College of Pharmacy and Health Sciences, Atlanta, Georgia, USA
    J Clin Psychiatry 73:e28. 2012
    ..MAOIs are useful treatment options for patients who have not responded to first-line treatments, and understanding their mechanism of action can help clinicians to accurately and safely prescribe these medications...